Identification of FABP7 as a Potential Biomarker for Predicting Prognosis and Antiangiogenic Drug Efficacy of Glioma

Figure 4

Correlation analysis between FABP7 expression and clinical characteristics using the CGGA dataset in glioma patients. Differential expression of FABP7 was significantly related to (a) age (<42, ; and ≥42, ), (b) grade (WHO II, ; WHO III, ; and WHO IV, ), (c) IDH mutation status (mutant, ; wildtype, ), (d) 1p19q codeletion status (codel, ; noncodel, ), and (e) chemo status (yes, ; no, ).

(a)

(b)

(c)

(d)

(e)